Vitamin K epoxide reductase complex subunit 1 (Vkorc1) haplotype diversity in mouse priority strains
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in BMC Research Notes
- Vol. 1 (1) , 125
Abstract
Polymorphisms in the vitamin K-epoxide reductase complex subunit 1 gene, Vkorc1, could affect blood coagulation and other vitamin K-dependent proteins, such as osteocalcin (bone Gla protein, BGP). Here we sequenced the Vkorc1 gene in 40 mouse priority strains. We analyzed Vkorc1 haplotypes with respect to prothrombin time (PT) and bone mineral density and composition (BMD and BMC); phenotypes expected to be vitamin K-dependent and represented by data in the Mouse Phenome Database (MPD).Keywords
This publication has 21 references indexed in Scilit:
- Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–AmericansPharmacogenomics, 2008
- Nucleotide Variation in Wild and Inbred MiceGenetics, 2007
- The Genetic Basis of Resistance to Anticoagulants in RodentsGenetics, 2005
- Arlequin (version 3.0): An integrated software package for population genetics data analysisEvolutionary Bioinformatics, 2005
- Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1Thrombosis and Haemostasis, 2005
- Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2Nature, 2004
- The Vitamin K-dependent CarboxylaseThrombosis and Haemostasis, 2002
- The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical studyThe Journal of Pathology, 2001
- DNASTAR's Lasergene Sequence Analysis Software2000
- Long-term Use of Oral Anticoagulants and the Risk of FractureArchives of internal medicine (1960), 1999